22 Results for "

Compound-52

" in MedChemExpress (MCE) Product Catalog:
Products (22)

22 Results for "Compound-52" in MCE Product Catalog:

15
15 Cited Publications
Referencia número: HY-15154
No. CAS: 212779-48-1
Pureza:  99.88%
Synonyms: Compound 52
Target:  

CDK

Áreas de investigación:  

Cancer

NG 52 is a potent, cell-permeable, selective, ATP-compatible and orally active Cdc28p and Pho85p kinase inhibitor with IC50s of 7 μM and 2 μM, respectively. NG 52 also inhibits the activity of phosphoglycerate kinase 1 (PGK1) with an IC50 of 2.5 μM. NG 52 is inactive against yeast kinases Kin28p, Srb10, and Cak1p .
loading...
    loading...
3
3 Cited Publications
Referencia número: HY-139092
No. CAS: 1332184-63-0
Pureza:  98.04%
Target:  

Interleukin Related

Áreas de investigación:  

Infection Cancer

IL-4-inhibitor-1 (compound 52) is an IL-4 inhibitor, with an EC50 of 1.81 µM .
loading...
    loading...
Referencia número: HY-150029
No. CAS: 2772655-86-2
Pureza:  99.83%
Target:  

Cannabinoid Receptor

Áreas de investigación:  

Neurological Disease

CB1/2 agonist 3 (compound 52), a potent non-selective cannabinoid ligand, is a CB1/CB2 (cannabinoid receptor) competitive agonist. CB1/2 agonist 3 acts on hCB1 and hCB2 with Ki values of 5.9 nM and 3.5 nM, respectively .
loading...
    loading...
Referencia número: HY-151243
No. CAS: 1964517-04-1
Target:  

Lactate Dehydrogenase

Áreas de investigación:  

Cancer

NCATS-SM1441 (compound 52) is a lactate dehydrogenase (LDH) inhibitor (IC50=40 nM). By inhibiting the activity of LDH, NCATS-SM1441 is able to reduce the production of lactic acid in cancer cells, helping to slow or stop the proliferation of cancer cells. NCATS-SM1441 can be used to study cancer metabolism .
loading...
    loading...
Referencia número: HY-143604
No. CAS: 2648551-72-6
Target:  

Ras

Áreas de investigación:  

Cancer

KRAS G12D inhibitor 11 is a potent inhibitor of KRAS G12D. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS G12D inhibitor 11 has the potential for the research of KRAS G12D-mediated cancer (extracted from patent WO2021108683A1, compound 52) .
loading...
    loading...
Referencia número: HY-15154R
No. CAS: 212779-48-1
Synonyms: Compound 52 (Standard)
Target:  

CDK Reference Standards

Áreas de investigación:  

Cancer

NG 52 (Standard) is the analytical standard of NG 52. This product is intended for research and analytical applications. NG 52 is a potent, cell-permeable, selective, ATP-compatible and orally active Cdc28p and Pho85p kinase inhibitor with IC50s of 7 μM and 2 μM, respectively. NG 52 also inhibits the activity of phosphoglycerate kinase 1 (PGK1) with an IC50 of 2.5 μM. NG 52 is inactive against yeast kinases Kin28p, Srb10, and Cak1p .
loading...
    loading...
Referencia número: HY-151514
No. CAS: 313981-44-1
Pureza:  99.76%
Target:  

Bacterial

Áreas de investigación:  

Infection

Antituberculosis agent-5 (compound 52) is a nitrofuranylamide derivative, inhibits M. tuberculosis UDP-Gal mutase. Antituberculosis agent-5 inhibits Glf activity with an IC50 value of 99 μM/mL and resists tuberculosis (TB) with a MIC value of 1.6 μg/mL .
loading...
    loading...
Referencia número: HY-175507
Target:  

Parasite TRP Channel

Áreas de investigación:  

Infection

TRPMPZQ-IN-1 (Compound 52) is a TRPMPZQ inhibitor, with an EC50 of 0.38 μM against TRPMPZQ from Spirometra erinaceieuropaei. TRPMPZQ-IN-1 exhibits antiparasitic activity, showing an EC50 of 4.3 μM against Echinococcus multilocularis. TRPMPZQ-IN-1 can be used in antiparasitic research .
loading...
    loading...
Referencia número: HY-175867
Target:  

PROTACs SWI/SNF Complex

Áreas de investigación:  

Cancer

PROTAC SMARCA2 degrader-34 (compound 52) is a selective SMARCA2 PROTAC degrader (DC50 in HeLa cell: < 0.1 μM for SMARCA2, > 1 μM for SMARCA4). PROTAC SMARCA2 degrader-34 can be used for study of cancer. (Pink: SMARCA2 ligand (HY-178414) ; Blue: E3 ligand (HY-168055) ; Black: linker) .
loading...
    loading...
Referencia número: HY-155425
No. CAS: 1313602-99-1
Target:  

ICMT

Áreas de investigación:  

Cancer

ICMT-IN-17 (compound 52) is an inhibitor of ICMT (IC50=0.38 μM) .
loading...
    loading...
Referencia número: HY-157578
No. CAS: 1018480-97-1
Target:  

COX

Áreas de investigación:  

Inflammation/Immunology

COX-2-IN-38 (compound 52*) is a potent inhibitor of COX-2, with the IC50 value of 79.4 nM .
loading...
    loading...
Referencia número: HY-162560
Target:  

LXR

Áreas de investigación:  

Cancer

Antitumor agent-162 (compound 52a) is a potent and orally active antitumor agent. Antitumor agent-162 shows cytotoxicity .
loading...
    loading...
Referencia número: HY-161625
No. CAS: 2950243-05-5
Target:  

Potassium Channel

Áreas de investigación:  

Neurological Disease

Kv7.2 modulator 2 (compound 52) is a Kv7.2 channel modulator and can be used for study of epilepsy .
loading...
    loading...
Referencia número: HY-161417
No. CAS: 2747216-27-7
Target:  

LIM Kinase (LIMK)

Áreas de investigación:  

Cancer

LIMK-IN-2 (Compound 52) is an LIMK inhibitor. LIMK-IN-2 can suppress the cell migration of osteosarcoma and cervical cancer cells, demonstrating potential anti-angiogenic activity .
loading...
    loading...
Referencia número: HY-169303
No. CAS: 3049339-96-7
Target:  

GPR35

Áreas de investigación:  

Inflammation/Immunology

Gpr35 modulator 2 (compound 52) is a GPR35 modulator. Gpr35 modulator 2 can be used for the study of a various GPR35-related disorders .
loading...
    loading...
Referencia número: HY-162442
Target:  

Ras

Áreas de investigación:  

Cancer

pan-KRAS-IN-9 (Compound 52) is an inhibitor for in human tumor mutated genes KRAS, which inhibits proliferation of KRAS mutated cells AsPC-1 (G12D mutant) and SW480 (G12V mutant) with IC50 of 0.24 and 0.30 nM, respectively .
loading...
    loading...
Referencia número: HY-119724
No. CAS: 1942919-63-2
Target:  

BCRP

Áreas de investigación:  

Cancer

ABCG2-IN-3 (Compound 52) is a selective inhibitor for breast cancer resistance protein (ABCG2), with an IC50 of 0.238 µM. ABCG2-IN-3 reverses the ABCG2-mediated resistance toward SN-38 and inhibit the ATPase activity .
loading...
    loading...
Referencia número: HY-112880
No. CAS: 1951464-78-0
Áreas de investigación:  

Infection Cancer

c-(2'FdAMP-2'FdIMP) (Compound 52),a derivative of cAIMP (HY-134375), is a cyclic dinucleotide (CDN). c-(2'FdAMP-2'FdIMP) is a STING activator and significantly induce STING-dependent IRF and NF-κB pathway signaling. c-(2'FdAMP-2'FdIMP) can be used for STING-based immunotherapy, such as cancers and infectious diseases research .
loading...
    loading...
Referencia número: HY-148449
No. CAS: 1402931-66-1
Áreas de investigación:  

Cancer

eIF4A3-IN-15 (compound 52) is a Silvestrol (HY-13251) analogue. eIF4A3-IN-15 interferes the assembling of eIF4F translation complex with EC50s of 11, 700 and 120 nM for myc-LUC, tub-LUC and the growth inhibition for MBA-MB-231 cells. eIF4A3-IN-15 can be used for the research of human cancer pathogenesis .
loading...
    loading...
Referencia número: HY-176996
No. CAS: 1136839-60-5
Target:  

DNA/RNA Synthesis

Áreas de investigación:  

Cancer

Ape1/Ref-1 redox-IN-1 (Compound 52) is an Ape1/Ref-1 redox inhibitor. Ape1/Ref-1 redox-IN-1 can be used in the research of cancer .
loading...
    loading...